| Author (Year) | ||||
| Journal | ||||
| Title | ||||
| Is the study eligible? | Yes | No | Maybe | Note |
| Type of study | ||||
| RCT? | ||||
| Not quasi‐RCT? | ||||
| Not cross‐over study? | ||||
| Not retracted study (see clinicaltrials.gov) or authored by Fujii and colleagues? | ||||
| Not abstract only? | ||||
| Types of participants | ||||
| Adults (≥ 18 yrs)? | ||||
| General anaesthesia? | ||||
| Types of intervention | ||||
| Monotherapy, or | ||||
| augmentation study (different class), or | ||||
| combination study (same class)? | ||||
| Substance class(es): | Name of drug(s):__________________________________________ | |||
| ‐ 5‐HT3 receptor antagonists | ||||
| ‐ D2 receptor antagonists | ||||
| ‐ NK‐1 receptor antagonists | ||||
| ‐ Corticosteroids | ||||
| ‐ Antihistamines | ||||
| ‐ Anticholinergics | ||||
| Drug allocated before onset of PONV? | ||||
| Similar baseline anaesthesia regimen in study's arms? | ||||